Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer

This publication has 27 references indexed in Scilit:

• The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone
  Fertility and Sterility, 2008
• Fertility and Menopausal Outcomes in Young Breast Cancer Survivors
  Clinical Breast Cancer, 2008
• Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast Cancer
  Journal of Clinical Oncology, 2006
• Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization
  Fertility and Sterility, 2003
• Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve
  Fertility and Sterility, 2002
• Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone
  Fertility and Sterility, 1999
• Ovarian reserve tests in infertility practice and normal fertile women
  Maturitas, 1998
• Treatment-independent pregnancy rate in patients with severe reproductive disorders
  Human Reproduction, 1998
• Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive Technologies
  Fertility and Sterility, 1998
• Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age
  Fertility and Sterility, 1991